Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-16

Clinical Trial Update: Tuberculosis Research of INA-RESPOND On Drug Resistance

View source ↗

Summary

The clinical trial update reports completion of the INA-RESPOND tuberculosis drug-resistance study, with results posted in May 2024. The study focused on pulmon…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ina-Respond | Conditions: Lung Tuberculosis, MDR TB | Status: COMPLETED | Results posted: 2024-05-16